martes, 29 de noviembre de 2016

Lung Cancer Awareness Month 3 | National Guideline Clearinghouse 3

Search | National Guideline Clearinghouse
Lung Cancer Awareness Month 3 |  National Guideline Clearinghouse 3
ngc

Health Awareness Topics: November 2016

  • GUIDELINE SUMMARY
  •  
  • NGC:010178
  •  
  • 2013

ACR Appropriateness Criteria® early-stage non–small-cell lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:007194
  •  
  • 2008 NOV (REAFFIRMED 2012)

Metastatic spinal cord compression. Diagnosis and management of adults at risk of and with metastatic spinal cord compression.

  • GUIDELINE SUMMARY
  •  
  • NGC:010021
  •  
  • 2013 SEP

Crizotinib for previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene.

  • GUIDELINE SUMMARY
  •  
  • NGC:009390
  •  
  • 2012 JAN

Superior sulcus (Pancoast) tumours.

  • GUIDELINE SUMMARY
  •  
  • NGC:010350
  •  
  • 2014 APR

Pemetrexed maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small-cell lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:009399
  •  
  • 2012 APR

Non-small cell lung cancer stage III.

  • GUIDELINE SUMMARY
  •  
  • NGC:010950
  •  
  • 2016 APR 5

Recommendations on screening for lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010793
  •  
  • 2015 AUG

British Thoracic Society guidelines for the investigation and management of pulmonary nodules.

  • GUIDELINE SUMMARY
  •  
  • NGC:010179
  •  
  • 1999 (REVISED 2013)

ACR Appropriateness Criteria® induction and adjuvant therapy for N2 non–small-cell lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010261
  •  
  • 2011 JUN (REVISED 2013 NOV)

Non-small cell lung cancer stage IV.

Management of lung cancer. A national clinical guideline.

No hay comentarios:

Publicar un comentario en la entrada